In courts across the nation, thousands of patients have filed lawsuits against drug manufacturers like AbbVie, claiming the companies’ testosterone supplements cause life-threatening side effects. More than 4,000 men have already filed their own Low T lawsuits, but each legal complaint is clear in its condemnation of a pharmaceutical industry that seems driven to put profits over people.
While the claims have been consolidated for pre-trial proceedings in Illinois, this isn’t a class action. Individual patients are filing individual lawsuits, and prominent testosterone lawyers believe thousands more may be entitled to pursue compensation.
Thousands Of Patients Have Filed Low T Lawsuits. You May Be Eligible, Too.
Testosterone replacement therapies come in many forms. There are gels, like AndroGel and Fortesta, injectable solutions like Delatestryl and dissolving tablets like Striant. More confusing? Each of these products is manufactured by a different company.
While most of the press has centered around AbbVie’s AndroGel, lawsuits are being filed in respect to numerous other testosterone products. Consolidated in Illinois, the current Low T lawsuits have been filed against 7 separate companies who make brand-name testosterone drugs, according to Forbes.
Perhaps more important than which type of Low T drug a patient was prescribed are the side effects that were caused by that drug. Testosterone lawyers are focusing their investigations on allegations that Low T products can cause cardiovascular complications, including:
- heart attack
- blood clots
A link has also been demonstrated between testosterone supplements and prostate cancer, so men who were diagnosed with a malignancy after being prescribed a Low T drug may be eligible to file suit.
Tragically, many survivors have also filed testosterone lawsuits on behalf of their deceased loved ones. This may still be possible for spouses who now find themselves widowed after losing a loved one to the side effects associated with testosterone use.
Scared To File? You Don’t Have To Be.
We speak to patients and families every day who know they have a viable case against a testosterone manufacturer. But time and again, they express the same fears. Lawsuits take time. Attorneys are expensive, and our family is already facing medical expenses higher than we can bear. We get that.
Lawsuits do take time, and it’s not easy. But most of the attorneys who can help you will work on a contingency-fee basis. That means you don’t pay them anything until they win in your case, whether that means negotiating an agreeable settlement or taking your case to court and securing a jury verdict. You can pursue the compensation you deserve and focus on recovering, at the same time.
If current allegations are anywhere close to the truth, you shouldn’t have to bear this burden alone. Low T lawsuits say drug manufacturers hid the risks of their products from patients and health care providers. They say patients by the millions are being deceived into taking these potentially deadly drugs, products that aren’t even approved for them to take.
This isn’t just a personal issue, although you and your loved ones may have suffered greatly. This is a matter of public health, of reigning in pharmaceutical companies who exploit patients because they can get away with it.
Why Are Patients Filing Testosterone Lawsuits?
Over the last decade, testosterone use has increased by leaps and bounds. Approved by the FDA for the treatment of hypogonadism, a medical condition characterized by abnormally low testosterone levels and a physical inability to produce the sex hormone, Low T drugs have somehow found their way into the hands of men without hypogonadism.
In fact, several studies have shown that around 25% of men currently taking testosterone replacement therapies never received a blood test. Instead, many of these patients are being “diagnosed” with the condition based on symptoms alone. Physicians, however, are clear on one thing: hypogonadism should only be diagnosed based on the results of a blood test and a thorough evaluation of a patient’s symptoms.
How So Many Men Ended Up Taking Testosterone
While it may be true that hypogonadism is more common than previously believed, testosterone isn’t just being used to treat hypogonadism anymore. It’s become increasingly clear that otherwise healthy men are taking Low T drugs, too. In their lawsuits, plaintiffs have suggested a troubling theory to explain how this happened: testosterone manufacturers sold the American public a lie.
Instead of marketing their drugs for use in men with hypogonadism, Low T companies chose a much wider pool of potential patients, older men in general. Through aggressive marketing, the manufacturers managed to make every normal aspect of the male aging process, including symptoms as indistinct as “grumpiness,” into proof-positive of a testosterone deficiency. They set up websites, allowing men to “diagnose” themselves, with a strange new medical condition called “Low T,” a medical condition testosterone was designed to treat.
Problem is, medical experts like Dr. Steven Woloshin, who spoke to AARP in August 2014, say “Low T” is made up. Woloshin called it the “mother of all disease mongering.” Disease mongering seems to work. By 2011, 1 out of every 25 men over the age of 65 were taking some type of Low T drug.
Side Effects: Blood Clots, Stroke, Heart Attack
Meanwhile, medical researchers around the globe have become extremely worried about testosterone’s effect on the body. It’s not hard to see why. Numerous studies have found a link between Low T supplements and severe cardiovascular side effects, up to and including heart attacks. A study conducted at Boston University in 2010 was even halted early, because “there was a significantly higher rate of adverse cardiovascular events in the testosterone group than in the placebo group.”
Even with this evidence, the manufacturers of testosterone drugs had to be forced by the US Food & Drug Administration to update their warning labels. First, the agency put a warning for “blood clots in the veins” on all approved testosterone products in June 2014. More recently, the FDA compelled the companies to warn patients and doctors about a “possible increased risk of heart attack and stroke.”
Over 4,000 patients and widows say those warnings have come too late.